Charles River Labs (CRL) Number Cut at Jefferies on Slower Start; 'Buy' Maintained
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Charles River Laboratories (CRL) Tops Q1 EPS by 8c; Boosts Outlook
April 30, 2014 4:43 PM EDTCharles River Laboratories (NYSE: CRL) reported Q1 EPS of $0.82, $0.08 better than the analyst estimate of $0.74. Revenue for the quarter came in at $299.4 million versus the consensus estimate of $302.08 million.
Charles River Laboratories sees FY2014 EPS of $3.15 - $3.25, versus prior guidance of $.00 - $3.10.... More
